A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen
Status:
Recruiting
Trial end date:
2022-06-06
Target enrollment:
Participant gender:
Summary
The main goal of this trial is to learn more about the safety of repeated dosing with Lu
AG09222. The trial doctors will keep track of the participant's overall health by asking them
how they are and by analyzing blood and urine samples.